FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease

Press/Media

Period	16 Jan 2025

Media coverage

Title	FDA Approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease
Media name/outlet	Drugs.com
Country/Territory	United States
Date	16/01/25
URL	https://www.drugs.com/newdrugs/fda-approves-lilly-s-omvoh-mirikizumab-mrkz-crohn-s-expanding-second-major-type-inflammatory-bowel-6435.html
Persons	Marla Dubinsky